Yannick Chantran Selected Research

Yannick Chantran Research Topics

4	Critical Illness (Critically Ill) 01/2024 - 01/2021
3	COVID-19 01/2024 - 10/2021
3	Hypersensitivity (Allergy) 05/2022 - 01/2019
2	Mastocytosis 11/2023 - 10/2023
2	Hereditary alpha-tryptasemia syndrome 10/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Peanut Hypersensitivity (Peanut Allergy) 01/2023 - 01/2021
2	Scleromyxedema (Lichen Myxedematosus) 03/2021 - 07/2020
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2019
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2014 - 09/2013
1	Mast Cell Activation Disorders (Mast-Cell Disease) 10/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Eosinophilia 01/2023
1	Food Hypersensitivity (Food Allergy) 01/2023
1	Seasonal Allergic Rhinitis (Hay Fever) 05/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Monoclonal Gammopathy of Undetermined Significance 03/2021
1	Paraproteinemias (Monoclonal Gammopathy) 07/2020
1	Mucinoses 07/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Arthritis (Polyarthritis) 04/2018
1	Purpura 04/2018
1	Cryoglobulinemia 04/2018
1	Dementia (Dementias) 01/2018
1	Cognitive Dysfunction 01/2018
1	Autoimmune Hepatitis 10/2012

3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2021
3	Immunoglobulin G (IgG)IBA 03/2021 - 04/2018
3	AntibodiesIBA 01/2021 - 10/2012
3	AutoantibodiesIBA 06/2014 - 10/2012
2	Tryptases (Tryptase)IBA 10/2023 - 01/2023
2	Immunoglobulin E (IgE)IBA 01/2023 - 01/2023
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024
1	staphylococcal enterotoxin BIBA 01/2023
1	Arthropod VenomsIBA 01/2023
1	Enterotoxins (Enterotoxin)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	GibberellinsIBA 05/2022
1	A 7 (A-7)IBA 05/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	P-SelectinIBA 01/2022
1	hexamidineIBA 11/2021
1	COVID-19 VaccinesIBA 10/2021
1	BNT162 VaccineIBA 10/2021
1	VaccinesIBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 03/2021
1	Nerve Growth Factor (NGF)IBA 07/2020
1	Amino Acids FDA Link 01/2019
1	AllergensIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	CryoglobulinsIBA 04/2018
1	Complement C4 (Complement Component 4)IBA 04/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Asialoglycoprotein ReceptorIBA 10/2012

1	Therapeutics 11/2023